Thierry Chauche

Insider Reports History

Location
Red Bank, NJ
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thierry Chauche:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Chief Financial Officer Series A Common Stock 59,688 $349,771 $5.86 19 Feb 2026 Direct
Sagimet Biosciences Inc. Chief Financial Officer Stock Option (Right to Buy) 88,000 19 Feb 2026 Direct
Provention Bio, Inc. Chief Financial Officer Option to Purchase Common Stock 0 27 Apr 2023 Direct

Insider Reports Filed by Thierry Chauche

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMT Sagimet Biosciences Inc. 19 Feb 2026 2 $0 4 Chief Financial Officer 20 Feb 2026, 16:39
SGMT Sagimet Biosciences Inc. 10 Feb 2026 1 -$7,033 4 Chief Financial Officer 12 Feb 2026, 16:07
SGMT Sagimet Biosciences Inc. 06 Feb 2025 2 $0 4 Chief Financial Officer 07 Feb 2025, 16:41
SGMT Sagimet Biosciences Inc. 06 May 2024 1 $0 4 Chief Financial Officer 08 May 2024, 16:06
SGMT Sagimet Biosciences Inc. 06 May 2024 0 $0 3 Chief Financial Officer 08 May 2024, 16:05
/report/000149315223013902-chauche-thierry-2023-04-27 Provention Bio, Inc. 27 Apr 2023 3 $0 4 Chief Financial Officer 27 Apr 2023, 18:00
/report/000149315223001207-chauche-thierry-2023-01-10 Provention Bio, Inc. 10 Jan 2023 1 $0 4 Chief Financial Officer 11 Jan 2023, 20:10
/report/000149315222001745-chauche-thierry-2022-01-18 Provention Bio, Inc. 18 Jan 2022 1 $0 4 Chief Financial Officer 20 Jan 2022, 16:17
/report/000149315221030243-chauche-thierry-2021-12-01 Provention Bio, Inc. 01 Dec 2021 1 $0 4 Chief Financial Officer 01 Dec 2021, 20:16
/report/000149315221030241-chauche-thierry-2021-12-01 Provention Bio, Inc. 01 Dec 2021 0 $0 3 Chief Financial Officer 01 Dec 2021, 20:13